Diagnosis and treatment of follicular lymphoma: an update.

Détails

ID Serval
serval:BIB_53A025DE33E4
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Diagnosis and treatment of follicular lymphoma: an update.
Périodique
Swiss medical weekly
Auteur(s)
Bargetzi M., Baumann R., Cogliatti S., Dietrich P.Y., Duchosal M., Goede J., Hitz F., Konermann C., Lohri A., Mey U., Novak U., Papachristofilou A., Stenner F., Taverna C., Zander T., Renner C.
ISSN
1424-3997 (Electronic)
ISSN-L
0036-7672
Statut éditorial
Publié
Date de publication
2018
Peer-reviewed
Oui
Volume
148
Pages
w14635
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: epublish
Résumé
Over the last few years, there have been many changes in the management of patients with follicular lymphoma, resulting in improvements in progression-free survival and quality of life. In addition to established regimens such as radiotherapy and immunochemotherapy, new treatment options are on the horizon. Furthermore, even the use of established chemotherapy agents has evolved, with new combinations moving to the forefront of the current treatment strategy. Nevertheless, there remains an unmet need for patients who have early relapses, those who are not responsive to anti-CD20 treatment regimens and for those in whom minimal residual disease persists even after immunochemotherapy. This review provides a summary of current developments in the diagnosis, treatment and management of follicular lymphoma, focusing on the clinical issues from a Swiss perspective.
Mots-clé
Antineoplastic Agents, Alkylating/therapeutic use, Antineoplastic Agents, Immunological/therapeutic use, Antineoplastic Combined Chemotherapy Protocols, Bendamustine Hydrochloride/therapeutic use, Combined Modality Therapy, Disease Management, Humans, Immunotherapy/methods, Lymphoma, Follicular/diagnosis, Lymphoma, Follicular/pathology, Lymphoma, Follicular/therapy, Neoplasm Grading, Positron Emission Tomography Computed Tomography, Quality of Life, Recurrence, Rituximab/therapeutic use, Survival Rate
Pubmed
Web of science
Open Access
Oui
Création de la notice
31/07/2018 11:37
Dernière modification de la notice
20/08/2019 15:08
Données d'usage